Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-11-007029
Filing Date
2011-02-24
Accepted
2011-02-24 12:03:41
Documents
1
Period of Report
2011-02-22

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3279
  Complete submission text file 0001225208-11-007029.txt   5223
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908-423-4840
Merck & Co. Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
KELLOGG PETER N (Reporting) CIK: 0001226287 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 11634900